Category Innovation/ R&D

Trade Secrets Directive Clears European Parliament Despite Concerns

Rejecting calls for a vote to be delayed until the European Commission proposes tougher whistle-blower protections, the European Parliament on 14 April approved by 503-131 new rules giving companies redress for theft or misuse of trade secrets. Debate on the trade secrets directive showed sharp divisions among lawmakers, heightened by the recent “Panama Papers” and other leaks, over whether the legislation will help businesses safeguard their innovative ideas or lead to increased corporate secrecy.

Landmark WIPO Conference On IP And Development Kicks Off

The role of intellectual property in economic, social and cultural development is at the heart of an international conference organised by the World Intellectual Property Organization this week. Today, a diverse range of speakers gave their views on the relationship between IP and innovation and creativity, with some describing in specific examples how IP helped their developing economies. Many speakers insisted on the need for developing countries to have policy space to define an IP system best suited to their development needs.

South African Trade Minister Opens WIPO Conference With Call For Appropriate IP

A two-day international conference on intellectual property and development opened today at the World Intellectual Property Organization with calls from speakers for the IP system to be applied by nations in ways appropriate to their economies, even if it means allowing copying - just as the biggest IP-holding nations did when they were developing years ago. The theme was set by the opening keynote speaker, South African Trade Minister Rob Davies.

Tribute To Brazilian Legal Scholar Denis Barbosa

Genius, brilliant, generous, wholehearted, warm, kind, funny, original, musician, art lover, brave, restless, these are few of the most suitable and recurrent attributes of Denis Borges Barbosa, who passed away on Saturday, April 2nd. Leading IP professor, researcher and attorney in Brazil, he was also the key international face of Brazilian IP, write Allan Rocha de Souza and Cláudia Chamas.

GSK Eases IP Rights For Poorest Countries, Considers Patent Pooling For Cancer

In light of the United Nations Secretary General’s High-Level Panel on Access to Medicines initiative, the GlaxoSmithKline company today announced steps to further help bring innovative medicines to poor countries.

US Tech Industry Associations Endorse TPP

A number of internet and software industry in the United States have come out in support of the Trans-Pacific Partnership (TPP) negotiated by the Office of the US Trade Representative (USTR) last year.

India, EU Leaders Touch On IPR, Innovation, ICTs, Pharmaceuticals

The leaders of India and the European Council today in Brussels discussed a wide range of topics including intellectual property rights - including geographical indications - innovation, digital issues, and health and pharmaceuticals.

Synthetic Biology: Is Scientific Progress Outrunning Normative Process? Case Of The CBD

A research group announced in March that it has designed the first minimal synthetic bacterial cell. Rapid advances in science seem to be leaving the international normative process lagging behind. Current international instruments are seeking to understand how this new technology will impact their regulatory efforts, while civil society raises high concerns.

Despite Supreme Court Ruling, Foreign Sales Don’t Affect US Patent Rights

The controversial ruling was perhaps to be expected. The Federal Circuit Court of Appeals doggedly hewed to its existing interpretation of patent law. Unfortunately, the court’s decision in Lexmark International v Impression Products conflicts with recent Supreme Court jurisprudence, according to many experts – thus leaving unresolved some important questions about how much control patentees can maintain over their patented products.

Special Report: India Rocked By Report Of Secret Assurance To US Industry On IP

That the Indian government has been under pressure from the United States to change its patent regime is no secret among those who follow the public discourse on intellectual property rights. Now, a new controversy about India’s alleged private assurance to the US-India Business Council (USIBC) and other lobby groups that it would not invoke compulsory licensing for commercial purposes seeks to add fuel to fiery speculation about a shift in India’s policy on IPR.